
TY  - JOUR
TI  - Invited speakers (Abstracts 1 to 26)
JO  - Clinical Oral Implants Research
VL  - 15
IS  - 4
SN  - 0905-7161
UR  - https://doi.org/10.1111/j.1600-0501.2004.t01-26-bmv_1.x
DO  - doi:10.1111/j.1600-0501.2004.t01-26-bmv_1.x
SP  - xxiii
EP  - lxxxviii
PY  - 2004
ER  - 

TY  - JOUR
AU  - Gianazza, Elisabetta
AU  - Vegeto, Elisabetta
AU  - Eberini, Ivano
AU  - Sensi, Cristina
AU  - Miller, Ingrid
TI  - Neglected markers: Altered serum proteome in murine models of disease
JO  - PROTEOMICS
JA  - Proteomics
VL  - 12
IS  - 4‐5
SN  - 1615-9853
UR  - https://doi.org/10.1002/pmic.201100320
DO  - doi:10.1002/pmic.201100320
SP  - 691
EP  - 707
KW  - Acute-phase reactant protein
KW  - Animal proteomics
KW  - Disease-specific protein
KW  - Species-specific protein
KW  - Transgenic mice
KW  - Transplanted cancer
PY  - 2012
AB  - Abstract More than a decade ago our groups pioneered the analysis of serum proteins of laboratory animals with up-to-date proteomic techniques. We were, and still are, convinced that conforming animal procedures to the minimally invasive approaches typical of clinical biochemistry focuses attention on the actual conditions under which any finding arrived at on animal models of disease may eventually be applied to human patients for screening/diagnosis. We are also convinced that, besides the proteins present in trace level as a result of tissue leakage during disorders affecting specific peripheral organs, changes in the concentration of some of the major serum proteins as part of an acute-phase response may be taken as biological end-points during a number of experimental procedures. When reviewing literature data about proteomic investigations on plasma or serum of mice, we realized that not much work has been done in the direction we favor. In addition, we noticed that sometimes information about serum proteome has been coarsely treated and in a few cases even misunderstood/misused. In the following, we present current findings on serum/plasma proteome of the laboratory mouse not only under control conditions and during an experimentally induced acute-phase reaction, but also in a number of models of disease, mainly related to cancer and to metabolic disorders.
ER  - 

TY  - JOUR
AU  - Arslan, Elif
AU  - Garip, I. Ceren
AU  - Gulseren, Gulcihan
AU  - Tekinay, Ayse B.
AU  - Guler, Mustafa O.
TI  - Bioactive Supramolecular Peptide Nanofibers for Regenerative Medicine
JO  - Advanced Healthcare Materials
JA  - Adv. Healthcare Mater.
VL  - 3
IS  - 9
SN  - 2192-2640
UR  - https://doi.org/10.1002/adhm.201300491
DO  - doi:10.1002/adhm.201300491
SP  - 1357
EP  - 1376
KW  - self-assembly
KW  - peptide amphiphile
KW  - regenerative medicine
KW  - bioactivity
KW  - scaffolds
PY  - 2014
AB  - Recent advances in understanding of cell?matrix interactions and the role of the extracellular matrix (ECM) in regulation of cellular behavior have created new perspectives for regenerative medicine. Supramolecular peptide nanofiber systems have been used as synthetic scaffolds in regenerative medicine applications due to their tailorable properties and ability to mimic ECM proteins. Through designed bioactive epitopes, peptide nanofiber systems provide biomolecular recognition sites that can trigger specific interactions with cell surface receptors. The present Review covers structural and biochemical properties of the self-assembled peptide nanofibers for tissue regeneration, and highlights studies that investigate the ability of ECM mimetic peptides to alter cellular behavior including cell adhesion, proliferation, and/or differentiation.
ER  - 

TY  - JOUR
TI  - Free Papers
JO  - Journal of Gastroenterology and Hepatology
VL  - 19
IS  - s5
SN  - 0815-9319
UR  - https://doi.org/10.1111/j.1440-1746.2004.t01-1-03624.x
DO  - doi:10.1111/j.1440-1746.2004.t01-1-03624.x
SP  - A296
EP  - A323
PY  - 2004
ER  - 

TY  - JOUR
AU  - Putnam, Sophie E.
AU  - Scutt, Andy M.
AU  - Bicknell, Katrina
AU  - Priestley, Caroline M.
AU  - Williamson, Elizabeth M.
TI  - Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health
JO  - Phytotherapy Research
JA  - Phytother. Res.
VL  - 21
IS  - 2
SN  - 0951-418X
UR  - https://doi.org/10.1002/ptr.2030
DO  - doi:10.1002/ptr.2030
SP  - 99
EP  - 112
KW  - osteoporosis
KW  - bone disorders
KW  - herbal medicines
KW  - nutraceuticals
KW  - diet
PY  - 2007
AB  - Abstract Bone metabolism involves a complex balance between the deposition of matrix and mineralization and resorption. There is now good evidence that dietary components and herbal products can influence these processes, particularly by inhibiting bone resorption, thus having beneficial effects on the skeleton. For example, it has been reported that a number of common vegetables, including onion, garlic and parsley, can inhibit bone resorption in ovariectomized rats. Essential oils derived from sage, rosemary, thyme and other herbs inhibit osteoclast activity in vitro and in vitro and leading to an increase in bone mineral density. Soya, a rich source of isoflavones, has shown promising results and epidemiological evidence to support a use in maintaining bone health, and various traditional herbal formulae in Chinese and Ayurvedic medicine also have demonstrable effects in pharmacological models of osteoporosis. Recently, cannabinoids have been described as having positive effects on osteoblast differentiation, and the presence of cannabinoid receptors in bone tissue indicates a more complex role in bone metabolism than previously thought. The first part of this review briefly discusses normal bone metabolism and disorders caused by its disruption, with particular reference to osteoporosis and current pharmacological treatments. The effects of natural products on bone and connective tissue are then discussed, to include items of diet, herbal extracts and food supplements, with evidence for their efficacy outlined. Copyright ? 2006 John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - TRANSPLANT 2001: The Joint American Transplant Meeting
JO  - American Journal of Transplantation
VL  - 1
IS  - S1
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2001.tb00014.x
DO  - doi:10.1111/j.1600-6143.2001.tb00014.x
SP  - 47
EP  - 476
PY  - 2001
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - APMIS
VL  - 117
IS  - s127
SN  - 0903-4641
UR  - https://doi.org/10.1111/j.1600-0463.2009.02504.x
DO  - doi:10.1111/j.1600-0463.2009.02504.x
SP  - 67
EP  - 180
PY  - 2009
ER  - 

C7  - pp. 483-505
TI  - Index
SN  - 9780470146934
UR  - https://doi.org/10.1002/9780470454923.index
DO  - doi:10.1002/9780470454923.index
SP  - 483-505
PY  - 2009
ER  - 

TY  - JOUR
TI  - Paediatric SIG
JO  - Respirology
VL  - 14
IS  - s1
SN  - 9780470146934
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_12.x
DO  - doi:10.1111/j.1440-1843.2009.01503_12.x
SP  - A75
EP  - A79
PY  - 2009
ER  - 

TY  - JOUR
TI  - Respiratory Infectious Disease SIG
JO  - Respirology
VL  - 14
IS  - s1
SN  - 9780470146934
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_14.x
DO  - doi:10.1111/j.1440-1843.2009.01503_14.x
SP  - A80
EP  - A83
PY  - 2009
ER  - 

TY  - JOUR
TI  - OLIV SIG 2 – Transplantation
JO  - Respirology
VL  - 14
IS  - s1
SN  - 9780470146934
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_11.x
DO  - doi:10.1111/j.1440-1843.2009.01503_11.x
SP  - A71
EP  - A75
PY  - 2009
ER  - 

TY  - JOUR
TI  - Sleep & Physiology SIG
JO  - Respirology
VL  - 14
IS  - s1
SN  - 9780470146934
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_16.x
DO  - doi:10.1111/j.1440-1843.2009.01503_16.x
SP  - A85
EP  - A89
PY  - 2009
ER  - 

TY  - JOUR
TI  - COPD SIG 1
JO  - Respirology
VL  - 14
IS  - s1
SN  - 9780470146934
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_5.x
DO  - doi:10.1111/j.1440-1843.2009.01503_5.x
SP  - A51
EP  - A54
PY  - 2009
ER  - 

TY  - JOUR
TI  - Respiratory Nurses SIG
JO  - Respirology
VL  - 14
IS  - s1
SN  - 9780470146934
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_15.x
DO  - doi:10.1111/j.1440-1843.2009.01503_15.x
SP  - A84
EP  - A85
PY  - 2009
ER  - 

TY  - JOUR
TI  - Asthma & Allergy SIG 3 – Paediatrics, Epidemiology and Physiology
JO  - Respirology
VL  - 14
IS  - s1
SN  - 9780470146934
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_3.x
DO  - doi:10.1111/j.1440-1843.2009.01503_3.x
SP  - A43
EP  - A46
PY  - 2009
ER  - 

TY  - JOUR
TI  - Interventional Pulmonology/Lung Cancer SIGs
JO  - Respirology
VL  - 14
IS  - s1
SN  - 9780470146934
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_8.x
DO  - doi:10.1111/j.1440-1843.2009.01503_8.x
SP  - A61
EP  - A64
PY  - 2009
ER  - 

TY  - JOUR
TI  - OELD/Population Health SIGs
JO  - Respirology
VL  - 14
IS  - s1
SN  - 9780470146934
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_9.x
DO  - doi:10.1111/j.1440-1843.2009.01503_9.x
SP  - A65
EP  - A67
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts from the XXXVIII Congress of the European Society for Artificial Organs (ESAO 2011) and IV Biennial Congress of the International Federation on Artificial Organs (IFAO 2011)
JO  - Artificial Organs
VL  - 35
IS  - 9
SN  - 9780470146934
UR  - https://doi.org/10.1111/j.1525-1594.2011.01335.x
DO  - doi:10.1111/j.1525-1594.2011.01335.x
SP  - A49
EP  - A141
PY  - 2011
ER  - 

TY  - JOUR
TI  - OLIV SIG 1 – ILD/PAH/Other
JO  - Respirology
VL  - 14
IS  - s1
SN  - 9780470146934
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_10.x
DO  - doi:10.1111/j.1440-1843.2009.01503_10.x
SP  - A67
EP  - A70
PY  - 2009
ER  - 

TY  - JOUR
TI  - Cell Biology/Immunology SIG
JO  - Respirology
VL  - 14
IS  - s1
SN  - 9780470146934
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_4.x
DO  - doi:10.1111/j.1440-1843.2009.01503_4.x
SP  - A46
EP  - A51
PY  - 2009
ER  - 
